Generics Division

Pioneers in launching
generic drugs

As part of our commitment to facilitating access to high-quality treatments for a greater number of patients, we develop generic drug products.

In 1997, Normon was the first laboratory to market the first three generics authorized in Spain and to conduct the first bioequivalence study.

We are currently one of the leading companies in the Spanish generic drug market, with a vade mecum of more than 236 active ingredients in over 1,200 presentations, covering key therapeutic areas such as:

Alimentary tract and metabolism

Antiinfectives

Blood and blood-forming organs

Antineoplastic and immunomodulating agents

Cardiovascular system

Musculoskeletal system

Genitourinary system

Nervous system

Systemic hormonal preparations

Respiratory system

New
pack design

The new packaging is designed to provide safety and confidence. At Normon, we don’t just improve the design, we improve the way we care for you.

Find out more

What are generic drugs?

  1. Ministerio de sanidad, política social e igualdad. Ventajas de los medicamentos genéricos; [Internet] [Accessed 3 Jul 2023] Available on: https://shorturl.at/dfjxD
  2. Garcia Arieta, A., C. Hernández García, and C. Avendaño Sóla. “Regulación de los medicamentos genéricos: evidencias y mitos.” Información Terapéutica del Sistema Nacional de Salud 34.3 (2010): 71-82.
  3. AESEG. Ficha informativa; Medicamentos genéricos: calidad, seguridad y eficacia asegurada [Internet] [Accessed 3 Jul 2023] Available on: https://www.aeseg.es/pdf aeseg fichas/fichal.pdf
  4. AESEG. Ficha informativa: La bioequivalencia: requisito imprescindible en medicamentos genéricos [Internet] [Accessed 3 Jul 2023] Available on: https://www.aeseg.es/pdf aeseg fichas/fichal.pdf
  5. Asociación Española de Medicamentos Genéricos. AESEG.En genéricos: engenérico; 07 Sep 2011 [Internet] [Accessed 3 Jul 2023] Available on: https://shorturl.at/ahmuz Agencia Española del medicamento. AEMPS.